miRNA-Based Ovarian Cancer Diagnosis and Therapy

作者: Rong Guo , Cheryl Sherman-Baust , Kotb Abdelmohsen

DOI: 10.1007/978-3-319-05134-5_6

关键词:

摘要: Ovarian cancer is the most lethal gynecological cancer. Two major obstacles facing increased patient survival rates are late diagnosis and lack of lasting, effective treatments. Numerous studies have shown that miRNAs altered in cells suggesting they play critical roles tumorigenesis. It has also been found possess a specific miRNA signature. In this chapter, we discuss ovarian signature promising impact circulating early treatment. We will focus on miRNA-based treatment utilizing inhibition or overexpression to alter Such therapy may consist alone combination with chemotherapy since can sensitize drugs reduce acquired chemoresistance. Although clinical trials using emerging, there remains need initiate

参考文章(88)
Pei-Ning Yu, Ming-De Yan, Hung-Cheng Lai, Rui-Lan Huang, Yu-Ching Chou, Wen-Chi Lin, Li-Tzu Yeh, Ya-Wen Lin, Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells. International Journal of Cancer. ,vol. 134, pp. 542- 551 ,(2014) , 10.1002/IJC.28399
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121
Claudine L. Bartels, Gregory J. Tsongalis, MicroRNA : nouveaux biomarqueurs des pathologies tumorales Annales De Biologie Clinique. ,vol. 68, pp. 263- 272 ,(2010) , 10.1684/ABC.2010.0429
Gábor Lendvai, András Kiss, Ilona Kovalszky, Zsuzsa Schaff, None, Alterations in microRNA expression patterns in liver diseases Orvosi Hetilap. ,vol. 151, pp. 1843- 1853 ,(2010) , 10.1556/OH.2010.28985
Shine Young Kim, Tae Yong Jeon, Chang In Choi, Dae Hwan Kim, Dong Heon Kim, Gwang Ha Kim, Dong Yup Ryu, Bong Eun Lee, Hyung Hoi Kim, Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer. The Journal of Molecular Diagnostics. ,vol. 15, pp. 661- 669 ,(2013) , 10.1016/J.JMOLDX.2013.04.004
Fanfei Kong, Chaoyang Sun, Zhongxian Wang, Lingfei Han, Danhui Weng, Yunping Lu, Gang Chen, miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1 Journal of Huazhong University of Science and Technology [Medical Sciences]. ,vol. 31, pp. 543- 549 ,(2011) , 10.1007/S11596-011-0487-Z
Claudine L Bartels, Gregory J Tsongalis, MicroRNAs: Novel Biomarkers for Human Cancer Clinical Chemistry. ,vol. 55, pp. 623- 631 ,(2009) , 10.1373/CLINCHEM.2008.112805
Phong Trang, Jason F Wiggins, Christopher L Daige, Chris Cho, Michael Omotola, David Brown, Joanne B Weidhaas, Andreas G Bader, Frank J Slack, Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice Molecular Therapy. ,vol. 19, pp. 1116- 1122 ,(2011) , 10.1038/MT.2011.48
Yu-mei Rao, Hui-rong Shi, Mei Ji, Cai-hong Chen, None, MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells Journal of Huazhong University of Science and Technology [Medical Sciences]. ,vol. 33, pp. 567- 572 ,(2013) , 10.1007/S11596-013-1160-5